Oligodendroglioma risk factors: Difference between revisions
Jump to navigation
Jump to search
(Mahshid) |
Sara Mohsin (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Oligodendroglioma}} | {{Oligodendroglioma}} | ||
{{CMG}}{{AE}}{{SR}} | {{CMG}}{{AE}}{{S.M.}}{{SR}} | ||
==Overview== | ==Overview== | ||
Revision as of 23:32, 29 April 2019
|
Oligodendroglioma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Oligodendroglioma risk factors On the Web |
|
American Roentgen Ray Society Images of Oligodendroglioma risk factors |
|
Risk calculators and risk factors for Oligodendroglioma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]Sujit Routray, M.D. [3]
Overview
The most potent risk factor in the development of oligodendroglioma is a positive family history of brain tumors.[1]
Risk Factors
The most potent risk factor in the development of oligodendroglioma is a positive family history of brain tumors.[1]
References
- ↑ 1.0 1.1 McCarthy BJ, Rankin KM, Aldape K, Bondy ML, Brännström T, Broholm H; et al. (2011). "Risk factors for oligodendroglial tumors: a pooled international study". Neuro Oncol. 13 (2): 242–50. doi:10.1093/neuonc/noq173. PMC 3064625. PMID 21149253.